Trump imposes 100% tariffs on drugmakers that won’t cut prices

On 2026-04-02, the Trump administration announced 100% tariffs on imported branded drugs from companies that have not agreed to lower U.S. prices or move production to the United States. The White House proclamation framed foreign dependence for patented medicines and pharmaceutical ingredients as a national security risk. The measure is intended to pressure drugmakers on pricing and domestic production.